학술논문

Mutations and variants of ONECUT1 in diabetes
Document Type
article
Source
Nature Medicine. 27(11)
Subject
Stem Cell Research
Autoimmune Disease
Diabetes
Clinical Research
Genetics
2.1 Biological and endogenous factors
Aetiology
Metabolic and endocrine
Cell Differentiation
Congenital Abnormalities
Diabetes Mellitus
Type 2
Fetal Growth Retardation
Gallbladder
Hepatocyte Nuclear Factor 6
Homeobox Protein Nkx-2.2
Homeodomain Proteins
Humans
Infant
Infant
Newborn
Male
Multifactorial Inheritance
Organogenesis
Pancreas
Pancreatic Diseases
Pluripotent Stem Cells
Transcription
Genetic
Medical and Health Sciences
Immunology
Language
Abstract
Genes involved in distinct diabetes types suggest shared disease mechanisms. Here we show that One Cut Homeobox 1 (ONECUT1) mutations cause monogenic recessive syndromic diabetes in two unrelated patients, characterized by intrauterine growth retardation, pancreas hypoplasia and gallbladder agenesis/hypoplasia, and early-onset diabetes in heterozygous relatives. Heterozygous carriers of rare coding variants of ONECUT1 define a distinctive subgroup of diabetic patients with early-onset, nonautoimmune diabetes, who respond well to diabetes treatment. In addition, common regulatory ONECUT1 variants are associated with multifactorial type 2 diabetes. Directed differentiation of human pluripotent stem cells revealed that loss of ONECUT1 impairs pancreatic progenitor formation and a subsequent endocrine program. Loss of ONECUT1 altered transcription factor binding and enhancer activity and NKX2.2/NKX6.1 expression in pancreatic progenitor cells. Collectively, we demonstrate that ONECUT1 controls a transcriptional and epigenetic machinery regulating endocrine development, involved in a spectrum of diabetes, encompassing monogenic (recessive and dominant) as well as multifactorial inheritance. Our findings highlight the broad contribution of ONECUT1 in diabetes pathogenesis, marking an important step toward precision diabetes medicine.